CTLT 60.98 (+2.21%)
US1488061029• Drug Manufacturers• Drug Manufacturers - Specialty & Generic
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. CTLT

Catalent (CTLT) Competitor Comparison

We are evaluating the key criteria listed to compare Catalent (CTLT) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Market Capitalization

4 / 54

Gross Profits

7 / 39

Total Revenue

7 / 50

EBITDA

7 / 53

Free Cashflow

50 / 54

Quick Ratio

38 / 54

Earnings per Share

46 / 54

Dividend yield

0 / 5

Total Cash

15 / 54

Performance 3 years

22 / 54

Performance 5 years

14 / 54

Performance 10 years

6 / 54

Linearity 3 years

25 / 54

Linearity 5 years

4 / 54

Linearity 10 years

31 / 54

Total Rank

8 / 54

Dividend Rank

51 / 54

Valuation Rank

2 / 54

Piotroski Rank

16 / 54

Muliplier Rank

7 / 54

Linearity 3 years - CTLT ranking 25 / 54

These are the competitors of Catalent in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. Kamada KMDA
23.86
2. Kolinpharma KIP.MI
11.59
3. Supernus Pharmaceuticals SUPN
11.25
4. Phibro Animal Health PAHC
10.34
5. Avadel Pharmaceuticals AVDL
9.44
6. Zoetis ZTS
9.41
7. Alimera Sciences ALIM
8.97
8. Perrigo PRGO
7.36
9. Alvotech ALVO
6.86
10. Vifor Pharma G2AB.F
6.24
11. ANI Pharmaceuticals ANIP
5.42
12. PetIQ PETQ
5.03
13. Cumberland Pharmaceuticals CPIX
4.69
14. Taro Pharmaceutical Industries TARO
3.87
15. ProPhase Labs PRPH
3.8
16. Ironwood Pharmaceuticals IRWD
3.55
17. Pacira BioSciences PCRX
3.41
18. Linc LNC
3.27
19. Journey Medical DERM
3.26
20. Collegium Pharmaceutical COLL
3.1
21. Zynerba Pharmaceuticals ZYNE
3
22. Cronos Group CRON
2.97
23. Regencell Bioscience Holdings RGC
2.96
24. Green Thumb Industries R9U2.F
2.92
25. Catalent CTLT
2.91
26. Elanco Animal Health ELAN
2.89
27. OptiNose OPTN
2.55
28. Embecta EMBC
2.52
29. Societal CDMO SCTL
2.41
30. Organogenesis Holdings ORGO
2.34
31. Amphastar Pharmaceuticals AMPH
2.3
32. Bausch Health Companies BHC
2.2
33. Curaleaf Holdings CURLF
2.2
34. Relmada Therapeutics RLMD
2.17
35. Procaps Group PROC
2.14
36. Eagle Pharmaceuticals EGRX
1.94
37. Emergent BioSolutions EBS
1.92
38. Evolus EOLS
1.86
39. Alpha Teknova TKNO
1.86
40. Jupiter Wellness JUPW
1.84
41. SCYNEXIS SCYX
1.82
42. Theratechnologies THTX
1.79
43. Solid Biosciences SLDB
1.77
44. Ascend Wellness Holdings AAWH
1.76
45. Flora Growth FLGC
1.74
46. Universe Pharmaceuticals UPC
1.74
47. Biofrontera BFRI
1.68
48. Tilray Brands TLRY
1.68
49. Neoleukin Therapeutics NLTX
1.57
50. Teva Pharmaceutical Industries TEVA
1.54
51. Clever Leaves Holdings CLVR
1.47
52. Ayr Wellness 3KJB.F
1.41
53. Amneal Pharmaceuticals AMRX
1.17
54. Harrow Health HROW
0.4
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.